BIZCHINA> Top Biz News
Shanghai-developed vaccine for A/H1N1 flu awaits approval
(Xinhua)
Updated: 2009-09-07 10:29

Shanghai Institute of Biological Products has been advised by the National Institute for the Control of Pharmaceutical and Biological Products in Beijing to have its H1N1 vaccine tested, the English Shanghai Daily reported Sunday.

Related readings:
Shanghai-developed vaccine for A/H1N1 flu awaits approval Chinese government orders 7.3m doses of A/H1N1 vaccine
Shanghai-developed vaccine for A/H1N1 flu awaits approval China approves one-dose homegrown H1N1 flu vaccine
Shanghai-developed vaccine for A/H1N1 flu awaits approval Sinovac Biotech cleared for H1N1 vaccine manufacture
Shanghai-developed vaccine for A/H1N1 flu awaits approval Green light for 2nd H1N1 flu vaccine
"We will send our vaccine for evaluation by a panel of experts for a production license," Shao Jun from the Shanghai institute was quoted as saying by the newspaper.

"The conference could be held next week," Shao said. If approved, the Shanghai manufacturer would be the country's third licensed mass producer of A/H1N1 flu vaccine.


(For more biz stories, please visit Industries)